Cipolat et al. found that mice that were triply deficient in envoplakin, periplakin, and involucrin (EPI−/− mice) were highly resistant to skin tumor development [136], indirectly suggesting a positive role of envoplakin and periplakin in skin cancer development. The gene discussed is PPL; the disease is skin cancer.